{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T02:12:12Z","timestamp":1770775932640,"version":"3.50.0"},"reference-count":9,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,5,28]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:p>A 46-year-old man with antiphospholipid syndrome (APS) and previous pulmonary embolism on anticoagulation with rivaroxaban was brought in to the hospital after a syncopal episode. He was found to be hypotensive and tachycardic and later admitted to the intensive care unit. Clinical presentation and laboratory findings were consistent with adrenal insufficiency. MRI revealed bilateral adrenal haemorrhage and he received appropriate steroid replacement therapy. Symptoms slowly subsided and anticoagulation regimen was changed to warfarin. Adrenal haemorrhage was likely caused by APS and rivaroxaban, which brings into question whether novel oral anticoagulants are safe in this patient population.<\/jats:p>","DOI":"10.1136\/bcr-2020-234947","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T02:24:44Z","timestamp":1593656684000},"page":"e234947","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Bilateral adrenal haemorrhage secondary to rivaroxaban in a patient with antiphospholipid syndrome"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8185-4707","authenticated-orcid":false,"given":"Marilyn A","family":"Arosemena","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Miami\/Jackson Memorial Hospital, Miami, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Miami\/Jackson Memorial Hospital, Miami, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasini","family":"Ediriweera","sequence":"additional","affiliation":[{"name":"Internal Medicine and Pediatrics, Jackson Memorial Hospital, Miami, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"key":"2025082708355788000_13.7.e234947.1","unstructured":"Elshimy G , Alghoula F , Jeong JM . Adrenal Crisis. In: 2019 Aug 22. StatPearls [Internet]. Treasure Island(FL): StatPearls Publishing, 2020."},{"key":"2025082708355788000_13.7.e234947.2","first-page":"4","article-title":"Idiopathic bilateral adrenal hemorrhage in a 63-year-old male: a case report and review of the literature","volume":"2015","author":"Dhawan","year":"2015","journal-title":"Case Rep Urol"},{"key":"2025082708355788000_13.7.e234947.3","unstructured":"Huecker MR , Dominique E . Adrenal Insufficiency. 2019 Aug 18. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2020."},{"key":"2025082708355788000_13.7.e234947.4","doi-asserted-by":"crossref","first-page":"829","DOI":"10.15537\/smj.2018.8.22437","article-title":"Bilateral adrenal hemorrhage in antiphospholipid syndrome. anticoagulation for the treatment of hemorrhage","volume":"39","author":"Aldaajani","year":"2018","journal-title":"Saudi Med J"},{"key":"2025082708355788000_13.7.e234947.5","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.12659\/AJCR.917780","article-title":"Rivaroxaban Related Bilateral Adrenal Hemorrhage: A Rare Complications of Direct Oral Anticoagulants - A Case Reports","volume":"20","author":"Alidoost","year":"2019","journal-title":"Am J Case Rep"},{"key":"2025082708355788000_13.7.e234947.6","article-title":"Adrenal hemorrhage in a patient anticoagulated with apixaban with antiphospholipid syndrome","volume":"11","author":"Sanford","year":"2019","journal-title":"Cureus"},{"key":"2025082708355788000_13.7.e234947.7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.7326\/M19-2815","article-title":"Direct oral anticoagulants in antiphospholipid syndrome: too early or too late?","volume":"171","author":"Wahl","year":"2019","journal-title":"Ann Intern Med"},{"key":"2025082708355788000_13.7.e234947.8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1310\/hpj5109-759","article-title":"Role of novel oral anticoagulants in the treatment of antiphospholipid syndrome","volume":"51","author":"White","year":"2016","journal-title":"Hosp Pharm"},{"key":"2025082708355788000_13.7.e234947.9","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/M19-0291","article-title":"Rivaroxaban versus vitamin K antagonist in antiphospholipid syndrome: a randomized Noninferiority trial","volume":"171","author":"Ordi-Ros","year":"2019","journal-title":"Ann Intern Med"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-234947","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:36:05Z","timestamp":1756308965000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-234947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":9,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,1]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/bcr-2020-234947"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-234947","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}